Home
Abstract
My Abstract(s)
Login
ePosters
Back
Final Presentation Format
Podium Abstract
Eposter Presentation
Eposter in PDF Format
Accept format: PDF. The file size should not be more than 5MB
Eposter in Image Format
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
Presentation Date / Time
Submission Status
Submitted
Abstract
Abstract Title
Concurrent Germline and Somatic Mutations in FLCN and Preliminary Exploration of Its Function
Presentation Type
Podium Abstract
Manuscript Type
Case Study
Abstract Category *
Oncology: Kidney (non-UTUC)
Author's Information
Number of Authors (including submitting/presenting author) *
2
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Country
China
Co-author 1
tao wang pekinguwt0919@126.com beijing friendship hospital urology beijing China *
Co-author 2
yinong niu xiehonglan605@yeah.net beijing friendship hospital urology beijing China
Co-author 3
Co-author 4
Co-author 5
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
Co-author 16
Co-author 17
Co-author 18
Co-author 19
Co-author 20
Abstract Content
Introduction
Birt–Hogg–Dube syndrome is an autosomal dominant condition that arises from germline folliculin (FLCN) mutations. It is characterized by skin fibrofolliculomas, lung cysts, pneumothorax, and renal cancer.
Materials and Methods
We present the case of a 36-year-old woman with asymptomatic, multiple renal tumors and a history of spontaneous pneumothorax.
Results
Genetic analysis revealed a hotspot FLCN germline mutation, c.1285dupC (p.H429fs), and a novel somatic mutation, c.470delT (p.F157fs). This information and the results of immunohistochemical analysis of the renal tumors indicated features compatible with a tumor suppressor role of FLCN. Two transcription factors, oncogenic TFEB and TFE3, were shown to be regulated by FLCN inactivation, which results in their nuclear localization. We showed that a deficiency in the tumor suppressor FLCN leads to deregulation of the mammalian target of rapamycin signaling (mTOR) pathway. A potential link between FLCN mutation and ciliary length was also examined.
Conclusions
Thus, the mutation identified in our patient provides novel insights into the relationship among FLCN mutations, TFEB/TFE3, mTOR, and cilia. However, an in-depth understanding of the role of folliculin in the molecular pathogenesis of renal cancer requires further study.
Keywords
Birt-Hogg-Dube (BHD) syndrome, folliculin (FLCN), mutation, renal cancer, TFEB/TFE3
Figure 1
https://storage.unitedwebnetwork.com/files/1237/d4698b1aaddfba99172f2aba4487e9ef.jpg
Figure 1 Caption
A diagnosis of BDH syndrome was confirmed in the patient.
Figure 2
https://storage.unitedwebnetwork.com/files/1237/c127b235f534b7dcfb53e5fea11af962.jpg
Figure 2 Caption
Immunostaining of the patient’s tumor tissue (A, D, G, J) and paracancerous tissue (B, E, H, K) and FLCN-positive control cancer tissue (C, F, I, L).
Figure 3
https://storage.unitedwebnetwork.com/files/1237/d0d2f6d7d8476bcc36d99959fde88b5d.jpg
Figure 3 Caption
The cilia are rarely expressed in tumor tissue (A) and cilia length was reduced in the adjacent tissue (B) and cilia were normally present in the tissues without the FLCN mutation (C).
Figure 4
Figure 4 Caption
Figure 5
Figure 5 Caption
Character Count
1255
Vimeo Link
Presentation Details
Session
Free Paper Podium(10): Oncology RCC (A)
Date
Aug. 15 (Fri.)
Time
16:12 - 16:18
Presentation Order
8